The high prices of brand-name prescription drugs are a growing source of controversy in the
United States. Manufacturers of brand-name drugs can command high prices because they …

Biological medicines contain a biological substance that is produced by or derived from a
living organism. The active substances of biologicals are usually larger and more complex …

Objective: To provide updated evidence on US trends in: market exclusivity periods (MEPs,
time between brand-name drug launch and first generic competitors) for new molecular …

Objective: To provide evidence on recent trends in:(1) market exclusivity periods (MEPs, the
time between launch of a brand-name drug and its first generic competitor) for new …

The cost of prescription drugs in the United States continues to be a source of concern for
patients, caregivers, and policymakers. Drug prices typically decline rapidly once generic …

Several large pharmaceutical companies have selectively downsized their neuroscience
research divisions, reflecting a growing view that developing drugs to treat brain diseases is …

Patent and regulatory exclusivity shall constitute incentives for pharmaceutical companies to
develop new drugs. This study aims to investigate the differences in the patent term …

Background Pharmacists being the drug experts need to be well aware of the applied
handling of biosimilar medicines (BSMs). They are an integral educator, trailblazer, and …

Innovation is essential for sustaining growth and economic development in a world that
faces population increase, natural resource depletion, and environmental challenges …

Antibacterial resistance is a growing global problem. According to the most recent statistics
from the Centers for Disease Control and Prevention (CDC), at least 2 million people …